EP 1357893 A2 20031105 - ACID COSMETIC, DERMATOLOGICAL AND PHARMACEUTICAL AGENTS
Title (en)
ACID COSMETIC, DERMATOLOGICAL AND PHARMACEUTICAL AGENTS
Title (de)
SAURE KOSMETISCHE, PHARMAZEUTISCHE UND DERMATOLOGISCHE MITTEL
Title (fr)
PRODUITS COSMETIQUES, PHARMACEUTIQUES ET DERMATOLOGIQUES ACIDES
Publication
Application
Priority
- DE 10059822 A 20001201
- EP 0113861 W 20011128
Abstract (en)
[origin: WO0243686A2] The invention relates to acid cosmetic, dermatological and pharmaceutical agents that contain at least one copolymer, obtainable by radical copolymerization of A) acryloyldimethyl taurine acid and/or acryloyldimethyl taurates, B) optionally one or more other olefinically unsaturated, non-cationic comonomers, C) optionally one or more olefinically unsaturated, cationic comonomers, D) optionally one or more silicon-containing component(s), E) optionally one or more fluorine-containing component(s), F) optionally one or more macromonomers, G) copolymerization optionally proceeding in the presence of at least one polymer additive, H) with the proviso that component A) is copolymerized with at least one component selected from groups D) to G).
IPC 1-7
IPC 8 full level
A61K 9/06 (2006.01); A61K 8/00 (2006.01); A61K 8/02 (2006.01); A61K 8/06 (2006.01); A61K 8/36 (2006.01); A61K 8/362 (2006.01); A61K 8/365 (2006.01); A61K 8/368 (2006.01); A61K 8/46 (2006.01); A61K 8/72 (2006.01); A61K 8/81 (2006.01); A61K 8/86 (2006.01); A61K 9/107 (2006.01); A61K 47/02 (2006.01); A61K 47/12 (2006.01); A61K 47/20 (2006.01); A61K 47/30 (2006.01); A61P 17/00 (2006.01); A61Q 5/02 (2006.01); A61Q 5/12 (2006.01); A61Q 19/00 (2006.01); A61Q 19/10 (2006.01); C08F 2/04 (2006.01); C08F 2/44 (2006.01); C08F 20/58 (2006.01); C08F 220/36 (2006.01); C08F 265/04 (2006.01); C08F 290/00 (2006.01); C08F 291/00 (2006.01); C08K 5/09 (2006.01); C08K 5/13 (2006.01); C08K 5/42 (2006.01); C08L 33/26 (2006.01); C08L 51/00 (2006.01); A61Q 5/00 (2006.01); A61Q 19/08 (2006.01)
CPC (source: EP US)
A61K 8/8158 (2013.01 - EP US); A61K 8/8182 (2013.01 - EP US); A61K 8/86 (2013.01 - EP US); A61P 17/00 (2017.12 - EP); A61Q 19/00 (2013.01 - EP US); C08F 265/04 (2013.01 - EP US); C08F 291/00 (2013.01 - EP US); C08L 51/003 (2013.01 - EP US); A61K 2800/54 (2013.01 - EP US); A61Q 5/006 (2013.01 - EP US); A61Q 19/007 (2013.01 - EP US); A61Q 19/08 (2013.01 - EP US); A61Q 19/10 (2013.01 - EP US); C08F 220/34 (2013.01 - EP US)
Citation (search report)
See references of WO 0243686A2
Citation (examination)
- WO 0244271 A2 20020606 - CLARIANT GMBH [DE], et al
- WO 0244270 A2 20020606 - CLARIANT GMBH [DE], et al
- WO 0244268 A1 20020606 - CLARIANT GMBH [DE], et al
- WO 0244267 A2 20020606 - CLARIANT GMBH [DE], et al
- WO 0244231 A1 20020606 - CLARIANT GMBH [DE], et al
- WO 0244230 A2 20020606 - CLARIANT GMBH [DE], et al
- WO 0244229 A1 20020606 - CLARIANT GMBH [DE], et al
- WO 0244227 A2 20020606 - CLARIANT GMBH [DE], et al
- WO 0244225 A2 20020606 - CLARIANT GMBH [DE], et al
- WO 0244224 A2 20020606 - CLARIANT GMBH [DE], et al
- WO 0243689 A2 20020606 - CLARIANT GMBH [DE], et al
- WO 0243688 A2 20020606 - CLARIANT GMBH [DE], et al
- WO 0243687 A2 20020606 - CLARIANT GMBH [DE], et al
- WO 0243677 A2 20020606 - CLARIANT GMBH [DE], et al
- WO 0210229 A1 20020207 - DEGUSSA BAUCHEMIE GMBH [DE], et al
- EP 1203789 A1 20020508 - OREAL [FR]
Designated contracting state (EPC)
DE ES FR GB IT
DOCDB simple family (publication)
WO 0243686 A2 20020606; WO 0243686 A3 20030912; BR 0115804 A 20030916; BR 0115804 B1 20150310; DE 10059822 A1 20020613; EP 1357893 A2 20031105; JP 2002205915 A 20020723; JP 5377812 B2 20131225; US 2004115148 A1 20040617; US 7025973 B2 20060411
DOCDB simple family (application)
EP 0113861 W 20011128; BR 0115804 A 20011128; DE 10059822 A 20001201; EP 01998319 A 20011128; JP 2001296935 A 20010927; US 43320403 A 20031117